Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771576 · ClinicalTrials.gov registry record
PET Scan Imaging of Beta Cell Mass
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 30
- Enrollment target
NCT00771576 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 30 participants.
The verdict
NCT00771576 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The investigators hypothesize that PET scans will be able to differentiate between normal, reduced or increased BCM in human subjects. Subjects with normal BCM will be recruited from among normal weight nondiabetic people with plasma insulin levels within the normal range. Subjects with predicted reduced BCM will be recruited from among patients with T1DM who have with low or not measurable insulin levels. If results from the nondiabetic subjects and the subjects with T1DM are found to differ significantly, subjects with increased BCM will be recruited from among patients with hyperinsulinemia including those with obesity and the metabolic syndrome. PET scan measurements of the pancreas will be obtained and compared in people predicted, on the basis of biochemical testing, to have normal or reduced, or increased BCM.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-06-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771576
The ClinicalTrials.gov registry entry for NCT00771576 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00771576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771576 about?
NCT00771576 is a clinical study titled "PET Scan Imaging of Beta Cell Mass". The investigators hypothesize that PET scans will be able to differentiate between normal, reduced or increased BCM in human subjects. Subjects with normal BCM will be recruited from among normal weight nondiabetic people with plasma insulin levels within the normal range. Subjects with predicted re...
What is the current status of trial NCT00771576?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-09. Estimated completion is 2012-06-13.
Who is sponsoring clinical trial NCT00771576?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.